1.5
1.50 (0.78%)
As of Mar 06, 2024
Regulus Therapeutics Inc. [RGLS]
Source:
Company Overview
Regulus Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing first-in-class drugs targeting microRNAs to treat diseases with significant unmet medical need.
| Country | United States |
| Headquarters | san diego, california |
| Phone Number | 858-202-6300 |
| Industry | manufacturing |
| CEO | Joseph P. Hagan |
| Website | www.regulusrx.com |